Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson; Ulrich Knigge; Gitte Dam; Birgitte Federspiel; Henning Grønbaek; Peter Stålberg; Seppo W. Langer; Andreas Kjaer; Johanna Arola; Camilla Schalin-Jäntti; Anders Sundin; Staffan Welin; Espen Thiis-Evensen; Halfdan Sorbye

doi:10.1080/0284186X.2021.1921262

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Eva Tiensuu Janson^*, Ulrich Knigge, Gitte Dam, Birgitte Federspiel, Henning Grønbaek, Peter Stålberg, Seppo W. Langer, Andreas Kjaer, Johanna Arola, Camilla Schalin-Jäntti, Anders Sundin, Staffan Welin, Espen Thiis-Evensen, Halfdan Sorbye

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

34 Citationer (Scopus)

45 Downloads (Pure)

Abstract

BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.

AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

Originalsprog	Engelsk
Tidsskrift	Acta Oncologica
Vol/bind	60
Udgave nummer	7
Sider (fra-til)	931-941
Antal sider	11
ISSN	1100-1704
DOI	https://doi.org/10.1080/0284186X.2021.1921262
Status	Udgivet - 2021

Bibliografisk note

Publisher Copyright:
© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Adgang til dokumentet

10.1080/0284186X.2021.1921262Licens: CC BY-NC-ND

Nordic guidelines 2021 for diagnosis andForlagets udgivne version, 1,75 MBLicens: CC BY-NC-ND

Citationsformater

Janson, E. T., Knigge, U., Dam, G., Federspiel, B., Grønbaek, H., Stålberg, P., Langer, S. W., Kjaer, A., Arola, J., Schalin-Jäntti, C., Sundin, A., Welin, S., Thiis-Evensen, E., & Sorbye, H. (2021). Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. Acta Oncologica, 60(7), 931-941. https://doi.org/10.1080/0284186X.2021.1921262

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. / Janson, Eva Tiensuu; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte; Grønbaek, Henning; Stålberg, Peter; Langer, Seppo W.; Kjaer, Andreas; Arola, Johanna; Schalin-Jäntti, Camilla; Sundin, Anders; Welin, Staffan; Thiis-Evensen, Espen; Sorbye, Halfdan.

I: Acta Oncologica, Bind 60, Nr. 7, 2021, s. 931-941.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Janson, ET, Knigge, U, Dam, G, Federspiel, B, Grønbaek, H, Stålberg, P, Langer, SW , Kjaer, A, Arola, J, Schalin-Jäntti, C, Sundin, A, Welin, S, Thiis-Evensen, E & Sorbye, H 2021, 'Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms', Acta Oncologica, bind 60, nr. 7, s. 931-941. https://doi.org/10.1080/0284186X.2021.1921262

Janson, Eva Tiensuu ; Knigge, Ulrich ; Dam, Gitte ; Federspiel, Birgitte ; Grønbaek, Henning ; Stålberg, Peter ; Langer, Seppo W. ; Kjaer, Andreas ; Arola, Johanna ; Schalin-Jäntti, Camilla ; Sundin, Anders ; Welin, Staffan ; Thiis-Evensen, Espen ; Sorbye, Halfdan. / Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. I: Acta Oncologica. 2021 ; Bind 60, Nr. 7. s. 931-941.

@article{7ecaff6649474746a64edd2a2c087597,

title = "Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms",

abstract = "BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.",

keywords = "Diagnosis, neuroendocrine carcinoma, neuroendocrine tumour, treatment",

author = "Janson, {Eva Tiensuu} and Ulrich Knigge and Gitte Dam and Birgitte Federspiel and Henning Gr{\o}nbaek and Peter St{\aa}lberg and Langer, {Seppo W.} and Andreas Kjaer and Johanna Arola and Camilla Schalin-J{\"a}ntti and Anders Sundin and Staffan Welin and Espen Thiis-Evensen and Halfdan Sorbye",

note = "Publisher Copyright: {\textcopyright} 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",

year = "2021",

doi = "10.1080/0284186X.2021.1921262",

language = "English",

volume = "60",

pages = "931--941",

journal = "Acta Oncologica",

issn = "1100-1704",

publisher = "Taylor & Francis",

number = "7",

}

TY - JOUR

T1 - Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

AU - Janson, Eva Tiensuu

AU - Knigge, Ulrich

AU - Dam, Gitte

AU - Federspiel, Birgitte

AU - Grønbaek, Henning

AU - Stålberg, Peter

AU - Langer, Seppo W.

AU - Kjaer, Andreas

AU - Arola, Johanna

AU - Schalin-Jäntti, Camilla

AU - Sundin, Anders

AU - Welin, Staffan

AU - Thiis-Evensen, Espen

AU - Sorbye, Halfdan

PY - 2021

Y1 - 2021

N2 - BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

AB - BACKGROUND: The diagnostic work-up and treatment of patients with gastroenteropancreatic (GEP) neuroendocrine neoplasms (NEN) has undergone major advances and new methods are introduced. Furthermore, an update of the WHO classification has resulted in a new nomenclature for GEP-NEN that is implemented in the clinic.AIM: These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat GEP-NEN patients and aims to be useful in the daily practice for clinicians.

KW - Diagnosis

KW - neuroendocrine carcinoma

KW - neuroendocrine tumour

KW - treatment

U2 - 10.1080/0284186X.2021.1921262

DO - 10.1080/0284186X.2021.1921262

M3 - Journal article

C2 - 33999752

VL - 60

SP - 931

EP - 941

JO - Acta Oncologica

JF - Acta Oncologica

SN - 1100-1704

IS - 7

ER -